Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

41 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Assessing Blood-Based Biomarkers to Define a Therapeutic Window for Natalizumab.
Granell-Geli J, Izquierdo-Gracia C, Sellés-Rius A, Teniente-Serra A, Presas-Rodríguez S, Mansilla MJ, Brieva L, Sotoca J, Mañé-Martínez MA, Moral E, Bragado I, Goelz S, Martínez-Cáceres E, Ramo-Tello C. Granell-Geli J, et al. Among authors: mansilla mj. J Pers Med. 2021 Dec 10;11(12):1347. doi: 10.3390/jpm11121347. J Pers Med. 2021. PMID: 34945819 Free PMC article.
Transfection of Vitamin D3-Induced Tolerogenic Dendritic Cells for the Silencing of Potential Tolerogenic Genes. Identification of CSF1R-CSF1 Signaling as a Glycolytic Regulator.
Mansilla MJ, González-Larreategui I, Figa-Martín N, Barallat J, Fondelli F, Sellés-Rius A, Quirant-Sánchez B, Teniente-Serra A, Martínez-Cáceres E. Mansilla MJ, et al. Int J Mol Sci. 2021 Jul 8;22(14):7363. doi: 10.3390/ijms22147363. Int J Mol Sci. 2021. PMID: 34298983 Free PMC article.
Paving the way towards an effective treatment for multiple sclerosis: advances in cell therapy.
Mansilla MJ, Presas-Rodríguez S, Teniente-Serra A, González-Larreategui I, Quirant-Sánchez B, Fondelli F, Djedovic N, Iwaszkiewicz-Grześ D, Chwojnicki K, Miljković Đ, Trzonkowski P, Ramo-Tello C, Martínez-Cáceres EM. Mansilla MJ, et al. Cell Mol Immunol. 2021 Jun;18(6):1353-1374. doi: 10.1038/s41423-020-00618-z. Epub 2021 May 6. Cell Mol Immunol. 2021. PMID: 33958746 Free PMC article. Review.
Tolerogenic dendritic cell-based treatment for multiple sclerosis (MS): a harmonised study protocol for two phase I clinical trials comparing intradermal and intranodal cell administration.
Willekens B, Presas-Rodríguez S, Mansilla MJ, Derdelinckx J, Lee WP, Nijs G, De Laere M, Wens I, Cras P, Parizel P, Van Hecke W, Ribbens A, Billiet T, Adams G, Couttenye MM, Navarro-Barriuso J, Teniente-Serra A, Quirant-Sánchez B, Lopez-Diaz de Cerio A, Inogés S, Prosper F, Kip A, Verheij H, Gross CC, Wiendl H, Van Ham MS, Ten Brinke A, Barriocanal AM, Massuet-Vilamajó A, Hens N, Berneman Z, Martínez-Cáceres E, Cools N, Ramo-Tello C; RESTORE consortium. Willekens B, et al. Among authors: mansilla mj. BMJ Open. 2019 Sep 9;9(9):e030309. doi: 10.1136/bmjopen-2019-030309. BMJ Open. 2019. PMID: 31501122 Free PMC article.
Clinical and immunological control of experimental autoimmune encephalomyelitis by tolerogenic dendritic cells loaded with MOG-encoding mRNA.
Derdelinckx J, Mansilla MJ, De Laere M, Lee WP, Navarro-Barriuso J, Wens I, Nkansah I, Daans J, De Reu H, Jolanta Keliris A, Van Audekerke J, Vanreusel V, Pieters Z, Van der Linden A, Verhoye M, Molenberghs G, Hens N, Goossens H, Willekens B, Cras P, Ponsaerts P, Berneman ZN, Martínez-Cáceres EM, Cools N. Derdelinckx J, et al. Among authors: mansilla mj. J Neuroinflammation. 2019 Aug 15;16(1):167. doi: 10.1186/s12974-019-1541-1. J Neuroinflammation. 2019. PMID: 31416452 Free PMC article.
41 results